Anti-viral compounds

US8541424B2 · kind B2 · utility

Assignee

• Abbott Laboratories · US

Inventors

• David A. DeGoey · Salem, US
• Pamela L. Donner · Mundelein, US
• Warren M. Kati · Gurnee, US
• Charles W. Hutchins · Libertyville, US
• Mark A. Matulenko · Libertyville, US
• Tammie K. Jinkerson · Pleasant Prairie, US
• Ryan G. Keddy · Beach Park, US

Key dates

• Filing date: Dec 22, 2009
• Grant date: Sep 24, 2013
• Expiry date: Nov 24, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.